Noninvasive Models to Predict Liver Fibrosis in Patients with Chronic Hepatitis B: A Study from Turkey
HEPATITIS MONTHLY, vol.17, no.12, 2017 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 17 Issue: 12
- Publication Date: 2017
- Doi Number: 10.5812/hepatmon.60266
- Journal Name: HEPATITIS MONTHLY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Open Archive Collection: AVESIS Open Access Collection
- Kocaeli University Affiliated: Yes
Abstract
Background: Manynoninvasive methods, including aspartateaminotransaminase (AST)/alanineaminotransaminase (ALT) ratio (AAR), AST-to-platelet ratio index (APRI), Bonacini cirrhosis discriminant score (CDS), fibrosis-4 (FIB4) index, and age-platelet index (API), have been described to determine the stage of hepatic fibrosis. However, thesemethodsare developed for patients with chronic hepatitisC(CHC) andproduce conflicting results in the prediction of liver fibrosis in patients with chronic hepatitis B (CHB).